Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Mass Spectrometry

• Publication date

  2006-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JMS.1112PMID 17051522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization.

  2007cited by this paper
• Demands on scientific studies in clinical toxicology.

  2007cited by this paper
• Validation of new methods.

  2007cited by this paper
• A Fully Automated Turbulent-Flow Liquid Chromatography-Tandem Mass Spectrometry Technique for Monitoring Antidepressants in Human Serum

  2006cited by this paper
• Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-beta-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques.

  2006cited by this paper
• New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques.

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.

  2006cited by this paper
• New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.

  2006cited by this paper
• State of the art in hair analysis for detection of drug and alcohol abuse.

  2006cited by this paper
• Toxicokinetics of Drugs of Abuse: Current Knowledge of the Isoenzymes Involved in the Human Metabolism of Tetrahydrocannabinol, Cocaine, Heroin, Morphine, and Codeine

  2006cited by this paper
• Fast gas chromatography-negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood.

  2006cited by this paper
• Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.

  2006cited by this paper
• Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.

  2006cited by this paper
• From fundamentals to applications: recent developments in atmospheric pressure photoionization mass spectrometry

  2006cited by this paper
• METABOLISM OF THE PSYCHOTOMIMETIC TRYPTAMINE DERIVATIVE 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE IN HUMANS: IDENTIFICATION AND QUANTIFICATION OF ITS URINARY METABOLITES

  2006cited by this paper
• Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry.

  2006cited by this paper
• An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.

  2006cited by this paper
• Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.

  2005cited by this paper
• Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry.

  2005cited by this paper
• The combination of liquid chromatography/tandem mass spectrometry and chip-based infusion for improved screening and characterization of drug metabolites.

  2005cited by this paper
• Combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry for the detection of 21 anabolic steroid residues in bovine urine.

  2005cited by this paper
• Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.

  2005cited by this paper
• The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.

  2005cited by this paper
• Toward High-Throughput Drug Screening Using Mass Spectrometry

  2005cited by this paper
• Quantitative Determination of the Calcium Channel Antagonists Amlodipine, Lercanidipine, Nitrendipine, Felodipine, and Lacidipine in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry

  2005cited by this paper
• Foundation review: Principles and applications of LC-MS in new drug discovery

  2005cited by this paper
• In vivo metabolite detection and identification in drug discovery via LC-MS/MS with data-dependent scanning and postacquisition data mining.

  2005cited by this paper
• An MS/MS library on an ion-trap instrument for efficient dereplication of natural products. Different fragmentation patterns for [M + H]+ and [M + Na]+ ions.

  2005cited by this paper
• Investigation of an LC-MS-MS (QTrap) method for the rapid screening and identification of drugs in postmortem toxicology whole blood samples.

  2005cited by this paper
• New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.

  2005cited by this paper
• Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins.

  2005cited by this paper
• Advances in analytical toxicology: the current role of liquid chromatography–mass spectrometry in drug quantification in blood and oral fluid

  2005cited by this paper
• Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer.

  2005cited by this paper
• Fast, Simple, and Validated Gas Chromatographic-Mass Spectrometric Assay for Quantification of Drugs Relevant to Diagnosis of Brain Death in Human Blood Plasma Samples

  2005cited by this paper
• New designer drug, 2,5-dimethoxy-4-propylthio-beta-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.

  2005cited by this paper
• Metabolism of designer drugs of abuse.

  2005cited by this paper
• Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.

  2005cited by this paper
• Review: Pharmacokinetics of illicit drugs in oral fluid.

  2005cited by this paper
• Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.

  2005cited by this paper
• Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.

  2005cited by this paper
• Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.

  2005cited by this paper
• LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings.

  2005cited by this paper
• A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.

  2005cited by this paper
• High-Performance Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory

  2005cited by this paper
• Applications of liquid chromatography-mass spectrometry in doping control.

  2005cited by this paper
• Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching.

  2005cited by this paper
• A study of ion suppression effects in electrospray ionization from mobile phase additives and solid-phase extracts.

  2004cited by this paper
• Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures.

  2004cited by this paper
• Comparison of product ion spectra obtained by liquid chromatography/triple-quadrupole mass spectrometry for library search.

  2004cited by this paper
• Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.

  2004cited by this paper
• Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

  2004cited by this paper
• Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization.

  2004cited by this paper
• Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data.

  2004cited by this paper
• Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types: A Synopsis

  2004cited by this paper
• Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.

  2004cited by this paper
• Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples.

  2004cited by this paper
• Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry.

  2003cited by this paper
• Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique.

  2003cited by this paper
• Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry.

  2003cited by this paper
• New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.

  2003cited by this paper
• Ion suppression in mass spectrometry.

  2003cited by this paper
• Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid

  2003cited by this paper
• A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry.

  2003cited by this paper
• Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.

  2003cited by this paper
• Identification of 2,5-dimethoxy-4-ethylthiophenethylamine and its metabolites in the urine of rats by gas chromatography-mass spectrometry.

  2003cited by this paper
• Evaluation of an improved general unknown screening procedure using liquid-chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography—diode array detection

  2003cited by this paper
• Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry.

  2003cited by this paper
• Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

  2003cited by this paper
• Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.

  2003cited by this paper
• Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.

  2003cited by this paper
• Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring.

  2003cited by this paper
• Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood.

  2003cited by this paper
• The encyclopedia of mass spectrometry

  2003cited by this paper
• Criteria for the identification of compounds by liquid chromatography–mass spectrometry and liquid chromatography–multiple mass spectrometry in forensic toxicology and doping analysis

  2003cited by this paper
• Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries.

  2002cited by this paper
• Progress of Liquid Chromatography–Mass Spectrometry in Clinical and Forensic Toxicology

  2002cited by this paper
• Negative Ion Chemical Ionization Gas Chromatography-Mass Spectrometry and Atmospheric Pressure Chemical Ionization Liquid Chromatography-Mass Spectrometry of Low-Dosed and/or Polar Drugs in Plasma

  2002cited by this paper
• Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases.

  2002cited by this paper
• Validated assay for quantification of oxcarbazepine and its active dihydro metabolite 10-hydroxycarbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography/mass spectrometry.

  2002cited by this paper
• Advances in the use of mass spectral libraries for forensic toxicology.

  2002cited by this paper
• In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites.

  2002cited by this paper
• Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry.

  2002cited by this paper
• Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives

  2002cited by this paper
• Progress of capillary electrophoresis in therapeutic drug monitoring and clinical and forensic toxicology.

  2002cited by this paper
• Drugs of Abuse Monitoring in Blood for Control of Driving Under the Influence of Drugs

  2002cited by this paper
• Bioanalytical method validation and its implications for forensic and clinical toxicology – A review

  2002cited by this paper
• Drug abuse's smallest victims: in utero drug exposure.

  2002cited by this paper
• Fast screening of anabolic steroids and other banned doping substances in human urine by gas chromatography/tandem mass spectrometry.

  2002cited by this paper
• Multiresidue determination method for organophosphorus pesticides in serum and whole blood by gas chromatography-mass-selective detection.

  2001cited by this paper
• Tune compounds for electrospray ionisation/in-source collision-induced dissociation with mass spectral library searching.

  2001cited by this paper
• Screening method for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography--electrospray ionization mass spectrometry.

  2001cited by this paper
• Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samples.

  2001cited by this paper
• Evaluation of electrospray transport CID for the generation of searchable libraries.

  2000cited by this paper
• Drugs in Nails

  2000cited by this paper
• A library of atmospheric pressure ionization daughter ion mass spectra based on wideband excitation in an ion trap mass spectrometer.

  2000cited by this paper
• Validated electrospray liquid chromatographic–mass spectrometric assay for the determination of the mushroom toxins α- and β-amanitin in urine after immunoaffinity extraction

  2000cited by this paper
• Validated electrospray liquid chromatographic-mass spectrometric assay for the determination of the mushroom toxins alpha- and beta-amanitin in urine after immunoaffinity extraction.

  2000cited by this paper
• Bioanalytical Method Validation—A Revisit with a Decade of Progress

  2000cited by this paper
• Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer.

  2000cited by this paper
• Comparison of algorithms and databases for matching unknown mass spectra

  1998cited by this paper

• DFT, Raman, FTIR, and SERS Spectroscopic Study of Trenbolone Acetate

  2026cites this paper
• Integrated GC-EI-HRMS and LC-ESI-HRMS workflow along with molecular networking for untargeted identification of new psychoactive substances.

  2026cites this paper
• Adduct formation by coeluting endogenous biomolecules using ESI-MS

  2025cites this paper
• Untargeted Mass Spectrometry Applications for Clinical Toxicology.

  2025cites this paper
• Validation of a procedure for toxicants detection in baits and animal organs in case of suspected poisoning by using GC-MS and LC-MS/MS, as a part of systematic toxicological analysis based on 15 years of experience.

  2025cites this paper
• Advancing drug testing in oral fluid: Comparison of microflow and analytical flow LC-Orbitrap analysis

  2025cites this paper
• Gene Doping Control Analysis of Human Erythropoietin Transgene in Equine Plasma by PCR-Liquid Chromatography High-Resolution Tandem Mass Spectrometry.

  2024cites this paper
• Determine the pharmacokinetics (half-life, volume of distribution and clearance) of AMB-FUBINACA in rats plasma using GC-MS / MS.

  2024cites this paper
• New Trend in Toxicological Screening Using Volumetric Absorptive Microsampling (VAMS) and High-Resolution Mass Spectrometry (HR/MS) Combination

  2023cites this paper
• Long time stability of 35 small endogenous biomolecules in dried urine spotted on various surfaces and environmental conditions.

  2022cites this paper
• Aurintricarboxylic acid mitigates cigarette smoke extract induced oxidative stress and pulmonary inflammation via inhibition of NF-ҡB/p65 signaling

  2022cites this paper
• A guide to good practice in chemometric methods for vibrational spectroscopy, electrochemistry, and hyphenated mass spectrometry

  2021cites this paper
• Introduction to Bioanalytical Mass Spectrometry

  2021cites this paper
• Applications of gas chromatography in forensic science

  2021cites this paper
• Toxicological screening reveals Toxic Epidermal Necrolysis likely carbamazepine-induced rather than idiopathic.

  2020cites this paper
• Mass Spectrometry

  2020cites this paper
• Drug screening by using the ToxtyperTM LC-ion trap MSn: optimization of its application on serum samples in a DUID context.

  2020cites this paper
• General Analytical Toxicology

  2020cites this paper
• High-throughput screening of toxic substances by extractive electrospray ionization mass spectrometry and their identification via databank construction

  2019cites this paper
• Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel.

  2019cites this paper
• Current and future directions of high resolution and tandem mass spectrometry in postmortem and human performance toxicology.

  2019cites this paper
• Evaluation of Direct from Sample Metabolomics of Human Faeces using Rapid Evaporative Ionisation Mass Spectrometry (REIMS).

  2019cites this paper
• Measurement of environmental contamination

  2018cites this paper
• DETECTION OF SOME DRUGS OF ABUSE FROM FINGERPRINTS USING LIQUID CHROMATOGRAPHYMASS SPECTROMETRY

  2017cites this paper
• Development of an Automated Metabolite-based Liquid Chromatographic-High Resolution Tandem Mass Spectrometric Drug Screening Procedure for Urine and Blood Plasma

  2017cites this paper
• Historical Development of Analytical Methods for Anti-Doping Control

  2017cites this paper
• Optimization and Validation of High-Resolution Mass Spectrometry Data Analysis Parameters.

  2017cites this paper
• Current status of non-targeted liquid chromatography-tandem mass spectrometry in forensic toxicology

  2016cites this paper
• Screening For Unknown Compounds in Forensic Toxicology

  2016cites this paper
• Comprehensive Urine Drug Screen by Gas Chromatography/Mass Spectrometry (GC/MS).

  2016cites this paper
• Clinical Applications of Mass Spectrometry in Drug Analysis

  2016cites this paper
• Broad-Spectrum Drug Screening Using Liquid Chromatography-Hybrid Triple-Quadrupole Linear Ion Trap Mass Spectrometry.

  2016cites this paper
• Development of a low volume dispersive liquid-liquid microextraction method for the simultaneous determination of illicit psychoactive drugs used by motorists in the Khomas region of Namibia

  2016cites this paper
• Derivatization of steroids in biological samples for GC-MS and LC-MS analyses.

  2015cites this paper
• Recent trends in analytical methods and separation techniques for drugs of abuse in hair.

  2014cites this paper
• Chromatographie en phase supercritique : nouvelles perspectives dans le domaine de l'analyse pharmaceutique

  2014cites this paper
• Toxicology of Specific Substances

  2014cites this paper
• Quality Assurance of forensic investigations in toxicology and traffic safety

  2014influential citation
• Analytical studies of morphine and related substances using LC-MS/MS

  2014cites this paper
• Development of a liquid chromatography ion trap mass spectrometer method for clinical drugs of abuse testing with automated on-line extraction using turbulent flow chromatography

  2014cites this paper
• ANALYTICAL METHODS FORTAXANES QUANTIFICATION IN DILUTED FORMULATIONS AND BIOLOGICAL SAMPLES AND THEIR APPLICATIONS IN CLINICAL PRACTICE

  2014cites this paper
• The development of direct infusion mass spectrometry method for analysis of small metabolites in urine

  2013cites this paper
• Clinical Validation of a Highly Sensitive GC-MS Platform for Routine Urine Drug Screening and Real-Time Reporting of up to 212 Drugs

  2013cites this paper
• Challenges in the development of bioanalytical liquid chromatography-mass spectrometry method with emphasis on fast analysis.

  2013cites this paper
• Comprehensive systematic toxicological analysis of human body fluids by parallel LC / MS / MS and GC / MS analysis

  2013influential citation
• [Sense and nonsense of toxicological analyses in the daily clinical routine].

  2013cites this paper
• Detection and identification of drugs and toxicants in human body fluids by liquid chromatography-tandem mass spectrometry under data-dependent acquisition control and automated database search.

  2013cites this paper
• How can analytical diagnostics in clinical toxicology be successfully performed today?

  2012cites this paper
• Identification and validated quantification of drugs of abuse, medicaments and their metabolites in blood and hair using liquid chromatographic : tandem mass spectrometric techniques in forensic toxicology and therapeutic drug monitoring

  2012cites this paper
• 10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.

  2012cites this paper
• Criterios cualitativos en toxicología forense

  2012cites this paper
• How Can Analytical Diagnostics in Clinical Toxicology Be Successfully Performed Today?

  2012cites this paper
• Systematic toxicological analysis using liquid chromatography-mass spectrometry: techniques and inter-instrument reproducibility of mass spectra/Systematisch-toxikologische Analyse mittels Hochleistungsflüssigchromatographie-Massenspektrometrie: Techniken und Reproduzierbarkeit von Massenspektren zw

  2012cites this paper
• Fast screening of 88 pharmaceutical drugs and metabolites in whole blood by ultrahigh-performance liquid chromatography–tandem mass spectrometry

  2012cites this paper
• GC-MS(n) and LC-MS/MS couplings for the identification of degradation products resulting from the ozonation treatment of Acetochlor.

  2012cites this paper
• Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument?

  2012cites this paper
• Rapid detection and quantification of 35 benzodiazepines in urine by GC-TOF-MS

  2012cites this paper
• Identification and validated quantification of drugs of abuse , medicaments and their metabolites in blood and hair using liquid chromatographic – tandem mass spectrometric techniques in forensic toxicology and therapeutic drug monitoring

  2012cites this paper
• Clinical proteomics: Current status, challenges, and future perspectives

  2011cites this paper
• Development of the first metabolite-based LC-MSn urine drug screening procedure-exemplified for antidepressants

  2011cites this paper
• Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

  2011cites this paper
• Quantitative determination of 43 common drugs and drugs of abuse in human serum by HPLC-MS/MS

  2011cites this paper
• A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part II).

  2011cites this paper
• Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology

  2011cites this paper
• LC-MS in analytical toxicology: some practical considerations.

  2011cites this paper
• Numerical Simulation and Experimental Validation of the Three-Dimensional Flow Field and Relative Analyte Concentration Distribution in an Atmospheric Pressure Ion Source

  2011cites this paper
• A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I).

  2011cites this paper
• Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines.

  2011cites this paper
• Prevalence of legal and illegal stimulating agents in sports

  2011cites this paper
• Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine.

  2010cites this paper
• Differentiation of structural isomers in a target drug database by LC/Q-TOFMS using fragmentation prediction.

  2010cites this paper
• Use of liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry for studying the metabolism of paynantheine, an alkaloid of the herbal drug Kratom in rat and human urine

  2010cites this paper
• Perspectives of Liquid Chromatography Coupled to Low- and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic Toxicology

  2010cites this paper
• Fast and simple procedure for liquid–liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic-tandem mass spectrometric quantification method in human blood plasma

  2010cites this paper
• Broad spectrum drug screening using electron-ionization gas chromatography-mass spectrometry (EI-GCMS).

  2010cites this paper
• An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography-tandem mass spectrometry.

  2010cites this paper
• Mass-spectrometry-based clinical proteomics--a review and prospective.

  2010cites this paper
• CEC‐ESI ion trap MS of multiple drugs of abuse

  2010cites this paper
• Broad spectrum drug screening using liquid chromatography-hybrid triple quadrupole linear ion trap mass spectrometry.

  2010cites this paper
• Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography-electron ionization-mass spectrometry.

  2010cites this paper
• History of doping and doping control.

  2010cites this paper
• Microwave-assisted derivatization procedures for gas chromatography/mass spectrometry analysis

  2010cites this paper
• Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.

  2010cites this paper
• Analytical toxicology

  2010cites this paper
• Hyphenations in planar chromatography.

  2010cites this paper
• QUALITY ASSURANCE ASPECTS OF IDENTIFICATION WITH CHROMATOGRAPHIC – MASS SPECTROMETRIC METHODS

  2009cites this paper
• Gas Chromatography in Forensic Science

  2009cites this paper
• Mass spectrometric approaches in impaired driving toxicology

  2009cites this paper
• Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasm

  2009cites this paper
• High-throughput experimentation platform: parallel microwave chemistry in HPLC/GC vials.

  2009cites this paper
• Retrospective drug detection in cases of drug-facilitated sexual assault: challenges and perspectives for the forensic toxicologist.

  2009cites this paper
• A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography–mass spectrometry

  2009cites this paper
• Applications of LC-MS/MS in forensic toxicology for the analysis of drugs and their metabolites

  2009cites this paper
• Construction of calibration-locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry

  2009cites this paper
• Application of Label-free Quantitative Peptidomics for the Identification of Urinary Biomarkers of Kidney Chronic Allograft Dysfunction*

  2009cites this paper
• An evaluation of microwave-assisted derivatization procedures using hyphenated mass spectrometric techniques.

  2009cites this paper
• New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.

  2009cites this paper
• Bedeutung der Analytik in der Klinischen Toxikologie: Auswirkungen auf die Diagnostik und Behandlung vergifteter Patienten / Analytical role in clinical toxicology: impact on the diagnosis and treatment of poisoned patients

  2009cites this paper
• Analytical role in clinical toxicology: impact on the diagnosis and treatment of poisoned patients

  2009cites this paper
• On the inter-instrument and inter-laboratory transferability of a tandem mass spectral reference library: 1. Results of an Austrian multicenter study.

  2009cites this paper